Company Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals.
The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.
It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy.
The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system.
The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020.
Zomedica Corp. is headquartered in Ann Arbor, Michigan.
| Country | United States |
| Founded | 2015 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 144 |
| CEO | Larry C. Heaton II |
Contact Details
Address: 100 Phoenix Drive, Suite 125 Ann Arbor, Michigan 48108 United States | |
| Phone | (734) 369-2555 |
| Website | zomedica.com |
Stock Details
| Ticker Symbol | ZOM |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001684144 |
| CUSIP Number | 98980M109 |
| ISIN Number | CA98980M1095 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Larry C. Heaton II | President, Chief Executive Officer and Director |
| Peter L. Donato BSBA, M.B.A. | Chief Financial Officer |
| Anthony K. Blair | Chief Operating Officer |
| Evan St. Peter M.B.A. | Vice President of Technology Innovation |
| Karen L. DeHaan-Fullerton J.D. | Chief Counsel and Corporate Secretary |
| Nicole Westfall M.B.A. | Senior Vice President of Marketing |
| Russell Kevin Klass | Senior Vice President of Sales |
| Kristin Domanski | Vice President of Human Resources |
| Greg Blair | Senior Vice President of Business Development and Strategic Planning |
| Robert W. DiMarzo | Consultant |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 4, 2024 | 8-K | Current Report |
| Apr 1, 2024 | 10-K | Annual Report |
| Mar 15, 2024 | 8-K | Current Report |
| Feb 29, 2024 | 8-K | Current Report |
| Feb 20, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Feb 6, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jan 31, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jan 26, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jan 24, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jan 17, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |